Cargando…
Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300558/ https://www.ncbi.nlm.nih.gov/pubmed/25589173 http://dx.doi.org/10.1186/s12964-014-0080-8 |
_version_ | 1782353538547974144 |
---|---|
author | Rizk, Shahir S Kouadio, Jean-Louis K Szymborska, Anna Duguid, Erica M Mukherjee, Somnath Zheng, Jiamao Clevenger, Charles V Kossiakoff, Anthony A |
author_facet | Rizk, Shahir S Kouadio, Jean-Louis K Szymborska, Anna Duguid, Erica M Mukherjee, Somnath Zheng, Jiamao Clevenger, Charles V Kossiakoff, Anthony A |
author_sort | Rizk, Shahir S |
collection | PubMed |
description | BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each hormone binding event triggers the appropriate response. FINDINGS: Here, we utilized a phage display library to generate synthetic antibodies (sABs) that preferentially modulate hPRL-R function in a hormone-dependent fashion. We determined the crystal structure of a sAB-hPRL-R complex, which revealed a novel allosteric mechanism of antagonism, whereby the sAB traps the receptor in a conformation more suitable for hGH binding than hPRL. This was validated by examining the effect of the sABs on hormone internalization via the hPRL-R and its downstream signaling pathway. CONCLUSIONS: The findings suggest that subtle structural changes in the extracellular domain of hPRL-R induced by each hormone determine the biological output triggered by hormone binding. We conclude that sABs generated by phage display selection can detect these subtle structural differences, and therefore can be used to dissect the structural basis of receptor-ligand specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-014-0080-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4300558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43005582015-01-22 Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling Rizk, Shahir S Kouadio, Jean-Louis K Szymborska, Anna Duguid, Erica M Mukherjee, Somnath Zheng, Jiamao Clevenger, Charles V Kossiakoff, Anthony A Cell Commun Signal Short Report BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each hormone binding event triggers the appropriate response. FINDINGS: Here, we utilized a phage display library to generate synthetic antibodies (sABs) that preferentially modulate hPRL-R function in a hormone-dependent fashion. We determined the crystal structure of a sAB-hPRL-R complex, which revealed a novel allosteric mechanism of antagonism, whereby the sAB traps the receptor in a conformation more suitable for hGH binding than hPRL. This was validated by examining the effect of the sABs on hormone internalization via the hPRL-R and its downstream signaling pathway. CONCLUSIONS: The findings suggest that subtle structural changes in the extracellular domain of hPRL-R induced by each hormone determine the biological output triggered by hormone binding. We conclude that sABs generated by phage display selection can detect these subtle structural differences, and therefore can be used to dissect the structural basis of receptor-ligand specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-014-0080-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-15 /pmc/articles/PMC4300558/ /pubmed/25589173 http://dx.doi.org/10.1186/s12964-014-0080-8 Text en © Rizk et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Rizk, Shahir S Kouadio, Jean-Louis K Szymborska, Anna Duguid, Erica M Mukherjee, Somnath Zheng, Jiamao Clevenger, Charles V Kossiakoff, Anthony A Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title | Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title_full | Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title_fullStr | Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title_full_unstemmed | Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title_short | Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
title_sort | engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300558/ https://www.ncbi.nlm.nih.gov/pubmed/25589173 http://dx.doi.org/10.1186/s12964-014-0080-8 |
work_keys_str_mv | AT rizkshahirs engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT kouadiojeanlouisk engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT szymborskaanna engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT duguidericam engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT mukherjeesomnath engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT zhengjiamao engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT clevengercharlesv engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling AT kossiakoffanthonya engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling |